Listed by the USPTO as PERREIRA, MELISSA JEAN
Tech Center 1600 • Art Units: 1618
This examiner grants 52% of resolved cases
Melissa Jean Perreira serves in Art Unit 1618 within Tech Center 1600, with 837 resolved cases. She has an allowance rate of 52.1 percent and a median days to allowance of 1375. These figures provide a baseline for understanding the frequency and timing of successful outcomes. The 1375 median days to allowance offers a benchmark for the duration of cases that reach allowance.
The interview lift of 25.7 percent is high, suggesting that interviews are a very effective strategy for securing an allowance. This lift significantly improves the 52.1 percent baseline allowance rate. The 25.7 percent lift indicates that direct communication with the examiner is a powerful factor in resolving outstanding issues. Practitioners should consider interviews as a key tactical move.
Top companies include University of Basel, The Johns Hopkins University, and Advanced Accelerator Applications SA. Firms such as GOODWIN PROCTER LLP, MORRISON & FOERSTER LLP, and MORSE, BARNES-BROWN & PENDLETON, P.C. are frequently involved. The 837 resolved cases offer a data set for evaluating the examiner's historical performance.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17542358 | PAPD5 AND PAPD7 INHIBITORS FOR TREATING A HEPATITIS B INFECTION | Non-Final OA | HOFFMANN-LA ROCHE INC. |
| 18062577 | HEMOSTATIC MATERIAL COMPOSITION | Non-Final OA | FUJIFILM CORPORATION |
| 19240908 | METHOD OF TREATING PROSTATE CANCER | Non-Final OA | Novartis AG |
| 16400922 | Pharmaceutical Compositions of Near IR Closed Chain, Sulfo-Cyanine Dyes | Final Rejection | Intuitive Surgical Operations, Inc. |
| 17040967 | METHODS AND ASSAYS FOR MODULATING GENE TRANSCRIPTION BY MODULATING CONDENSATES | Final Rejection | Massachusetts Institute of Technology |
| 18990863 | IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA) | Final Rejection | The Johns Hopkins University |
| 18052804 | PSMA-TARGETING COMPOUNDS AND USES THEREOF | Non-Final OA | The Johns Hopkins University |
| 18321684 | ACTIVITY-BASED PROBE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | Non-Final OA | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy52.1% of resolved applications examined by Melissa Jean Perreira were allowed (837 resolved cases), compared with 33.1% across Art Unit 1618 over the last five years.
This examiner's interview lift is +25.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Melissa Jean Perreira took 1,375 days on average from filing to allowance.
Melissa Jean Perreira examines applications in Art Unit 1618 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
